LIVE
NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

AUROPHARMA

NSEBSE
F&O
Aurobindo Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE406A01037· Scrip: 524804
ENहिन्दीગુજરાતીमराठी
₹૧,૪૮૩.૨૦
▲ 55.10 (+3.86%)
6/5/2026, 3:28:22 pm
NSE
₹૧,૪૮૩.૨૦
▲ ૫૫.૧૦
+૩.૮૬%
BSE
₹૧,૪૮૩.૪૦
▲ ૫૫.૨૦
+૦.૦૦%
1,0171,1361,2541,3731,49105-0607-0108-2810-2712-2302-2004-2905-06
૨૪૫ ટ્રેડિંગ દિવસ · 1Y સમયગાળો
આજ
ખૂલ્લ૧,૪૩૧.૦૦
ઊંચ૧,૪૮૯.૭૦
નીચ૧,૪૨૬.૧૦
અગાઉ બંધ૧,૪૨૮.૧૦
વૉલ્યુમ૨૪.૦૭L
મૂલ્ય₹૩૫૪.૧Cr
L: 1,426.10H: 1,489.70
52 સપ્તાહ
નીચ₹૧,૦૧૬.૧૦
ઊંચ₹૧,૪૮૯.૭૦
૯૯% 52 સપ્તાહ રેન્જમાં
માહિતી
અંકિત મૂલ્ય₹૧
સૂચિબદ્ધ2000-07-19
ISININE406A01037
SeriesA
BSE સ્ક્રિપ524804

મુખ્ય સૂચકો

1D
+3.86%
1W
+4.26%
1M
+10.51%
3M
+30.97%
6M
+34.95%
મૂલ્યાંકન
P/E (TTM)૨૯.૮૫
P/E (Qtr Ann.)૨૫.૪૭
P/Sales૨.૮૫
વૃદ્ધિ (ત્રિ.)
આવક+2.34%
PAT+3.50%
EPS+4.00%
નફાકારકતા
TTM EBITDA M.૨૦.૬%
TTM આવક
₹25815 Cr
TTM EBITDA
₹5316 Cr
TTM PAT
₹2899 Cr
TTM EPS
₹૪૯.૬૯

ત્રિમાસિક નાણાકીય

આવક
EBITDA
PAT
EPS
0 Cr1995 Cr3989 Cr5984 Cr7979 Cr22-1223-0323-0923-1224-0324-0624-0924-12₹8.4₹8.6₹12.8₹16.0₹15.5₹5.6₹14.0₹14.6
ત્રિમાસઆવકExpensesEBITDAPBTPATEPS
2024-12-317979 Cr6938 Cr1617 Cr1198 Cr846 Cr₹14.56
2024-09-307796 Cr6725 Cr1589 Cr1207 Cr817 Cr₹14.00
2024-06-302460 Cr2079 Cr513 Cr446 Cr329 Cr₹5.62
2024-03-317580 Cr6351 Cr1597 Cr1243 Cr907 Cr₹15.51
2023-12-317352 Cr6249 Cr1688 Cr1265 Cr940 Cr₹16.04
2023-09-307219 Cr6332 Cr1492 Cr1075 Cr752 Cr₹12.83
2023-03-316473 Cr5872 Cr1081 Cr736 Cr506 Cr₹8.64
2022-12-316407 Cr5819 Cr1002 Cr681 Cr491 Cr₹8.38

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન — 2026-03-31
51.8%પ્રમોટર
પ્રમોટર51.8%
FII15.2%
DII25.9%
સાર્વજનિક48.2%
પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ
51.8%24-0651.8%24-0951.8%24-1251.8%25-0351.8%25-0951.8%25-1251.8%26-03

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખપ્રકારહેતુ
2026-04-17OtherBuy Back
2025-08-08DividendInterim Dividend - Rs 4 Per Share
2024-08-26OtherAnnual General Meeting
2024-07-30OtherBuy Back
2024-02-20DividendInterim Dividend - Rs 1.50 Per Share
2023-11-20DividendInterim Dividend - Rs 3 Per Share
2023-08-22OtherAnnual General Meeting
2023-02-17DividendInterim Dividend - Rs 3 Per Share
2022-07-27OtherAnnual General Meeting
2022-06-06DividendInterim Dividend - Rs 4.50 Per Share
2022-02-18DividendInterim Dividend - Rs 1.50 Per Share
2021-11-17Dividend Interim Dividend - Rs 1.50 Per Share
2021-08-27Dividend Interim Dividend - Rs 1.50 Per Share
2021-08-20Other Annual General Meeting
2021-02-22Dividend Interim Dividend - Rs 1.50 Per Share
2020-11-23Dividend Interim Dividend - Rs 1.25 Per Share
2020-08-21Dividend Annual General Meeting/Interim Dividend - Rs 1.25 Per Share
2020-02-17Dividend Interim Dividend - Rs 1.75 Per Share
2019-11-21Dividend Interim Dividend - Rs 1.25 Per Share
2019-08-21Other Annual General Meeting

કમાણી ટ્રાન્સક્રિપ્ટ

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
5 Nov 2025NSE15K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
4 Aug 2025NSE14K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
26 May 2025NSE15K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
6 Feb 2025NSE16K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE16K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
27 May 2023NSE14K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated February 3, 2...
10 Feb 2023NSE1K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
9 Feb 2023NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, ...
3 Feb 2023NSE2K chars
Read →
Sub: Transcript of Q2FY23 earnings call.Please refer to our letter dated November 8, 2022 wherein we...
18 Nov 2022NSE51K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated November 8, 2...
14 Nov 2022NSE1K chars
Read →
Please refer to our letter dated November 8, 2022 wherein we have intimated the schedule of Investor...
12 Nov 2022NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Re...
8 Nov 2022NSE2K chars
Read →
Further to our letter dated September 6, 2022 informing about the participation in the Kotak Institu...
7 Sept 2022NSE2K chars
Read →
Please refer to our letter dated August 8, 2022 wherein we have intimated the schedule of Investors/...
19 Aug 2022NSE55K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 8, 202...
12 Aug 2022NSE1K chars
Read →
Please refer to our letter dated August 8, 2022 wherein we have intimated the schedule of Investors/...
11 Aug 2022NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Re...
8 Aug 2022NSE2K chars
Read →
Please refer to our letter dated May 26, 2022 wherein we have intimated the schedule of Investors/ A...
6 Jun 2022NSE50K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated May 26, 2022,...
31 May 2022NSE1K chars
Read →

ભાવ ઇતિહાસ

તારીખખૂલ્લઊંચનીચબંધવૉલ્યુમ
2026-05-06૧,૪૩૧.૦૦૧,૪૮૯.૭૦૧,૪૨૬.૧૦૧,૪૮૪.૦૦૨૪.૨૧L
2026-05-05૧,૩૭૩.૯૦૧,૪૩૧.૦૦૧,૩૬૭.૦૦૧,૪૨૮.૧૦૧૮.૧૨L
2026-05-04૧,૩૯૮.૦૦૧,૩૯૮.૦૦૧,૩૬૭.૧૦૧,૩૭૬.૦૦૭.૭૮L
2026-04-30૧,૩૯૨.૦૦૧,૪૦૪.૦૦૧,૩૭૮.૬૦૧,૩૮૯.૫૦૬.૦૬L
2026-04-29૧,૪૨૫.૯૦૧,૪૩૩.૦૦૧,૩૮૯.૩૦૧,૩૯૬.૮૦૧૭.૩૯L
2026-04-28૧,૪૧૫.૦૦૧,૪૩૦.૦૦૧,૪૧૦.૩૦૧,૪૨૨.૬૦૮.૪૮L
2026-04-27૧,૪૧૪.૯૦૧,૪૩૩.૪૦૧,૩૮૬.૬૦૧,૪૧૬.૭૦૯.૯૮L
2026-04-24૧,૪૩૬.૯૦૧,૪૪૬.૦૦૧,૪૧૧.૭૦૧,૪૧૩.૮૦૯.૬૮L
2026-04-23૧,૪૨૦.૦૦૧,૪૫૯.૫૦૧,૪૦૯.૧૦૧,૪૩૫.૪૦૨૨.૩૮L
2026-04-22૧,૩૮૯.૫૦૧,૪૨૫.૧૦૧,૩૮૨.૪૦૧,૪૨૧.૨૦૧૭.૦૪L
2026-04-21૧,૩૬૮.૯૦૧,૪૦૧.૧૦૧,૩૬૭.૧૦૧,૩૯૧.૭૦૧૩.૬૩L
2026-04-20૧,૩૯૨.૦૦૧,૩૯૨.૦૦૧,૩૬૩.૫૦૧,૩૬૭.૮૦૭.૦૭L
2026-04-17૧,૩૮૮.૯૦૧,૩૯૪.૯૦૧,૩૭૫.૩૦૧,૩૮૬.૦૦૧૬.૧૨L
2026-04-16૧,૩૮૯.૯૦૧,૩૮૯.૯૦૧,૩૬૮.૦૦૧,૩૮૬.૫૦૨૨.૫૪L
2026-04-15૧,૩૫૦.૦૦૧,૩૭૯.૨૦૧,૩૪૫.૮૦૧,૩૭૩.૯૦૧૮.૩૦L
2026-04-13૧,૩૪૦.૦૦૧,૩૫૩.૦૦૧,૩૩૩.૦૦૧,૩૩૯.૮૦૧૩.૭૮L
2026-04-10૧,૩૪૫.૦૦૧,૩૫૫.૦૦૧,૩૩૬.૮૦૧,૩૪૯.૪૦૯.૦૭L
2026-04-09૧,૩૩૫.૦૦૧,૩૪૬.૭૦૧,૩૨૧.૬૦૧,૩૪૦.૪૦૯.૩૯L
2026-04-08૧,૩૬૨.૭૦૧,૩૬૩.૦૦૧,૩૧૬.૮૦૧,૩૩૫.૭૦૩૨.૫૬L
2026-04-07૧,૩૪૫.૦૦૧,૩૫૭.૫૦૧,૩૧૬.૦૦૧,૩૩૦.૦૦૧૫.૫૮L
2026-04-02૧,૩૩૫.૫૦૧,૩૩૮.૯૦૧,૨૬૬.૧૦૧,૩૩૩.૭૦૧૮.૭૦L
2026-04-01૧,૩૩૨.૨૦૧,૩૫૯.૯૦૧,૩૨૫.૯૦૧,૩૪૨.૧૦૨૫.૯૫L
2026-03-27૧,૩૦૭.૮૦૧,૩૨૭.૦૦૧,૨૯૬.૦૦૧,૩૧૪.૨૦૧૯.૨૪L
2026-03-25૧,૨૯૦.૪૦૧,૩૩૦.૦૦૧,૨૮૨.૧૦૧,૩૦૭.૮૦૧૮.૯૨L
2026-03-24૧,૩૦૩.૦૦૧,૩૧૦.૦૦૧,૨૫૫.૪૦૧,૨૮૧.૬૦૧૭.૬૯L
2026-03-20૧,૨૬૨.૦૦૧,૨૯૭.૮૦૧,૨૫૮.૩૦૧,૨૯૧.૪૦૧૩.૯૬L
2026-03-19૧,૨૫૫.૦૦૧,૨૬૯.૦૦૧,૨૪૦.૦૦૧,૨૪૭.૫૦૮.૧૭L
2026-03-18૧,૨૭૮.૦૦૧,૨૯૦.૫૦૧,૨૬૫.૩૦૧,૨૬૯.૦૦૧૭.૦૦L
2026-03-17૧,૨૮૪.૯૦૧,૨૯૫.૦૦૧,૨૭૫.૧૦૧,૨૮૬.૦૦૬.૩૫L
2026-03-16૧,૩૦૨.૦૦૧,૩૧૪.૦૦૧,૨૬૫.૮૦૧,૨૭૯.૬૦૧૪.૩૭L

વારંવાર પૂછાતા પ્રશ્નો

વિશે

ઓરોબિંદો ફાર્મા લિમિટેડ એ હૈદરાબાદ સ્થિત એક ભારતીય બહુરાષ્ટ્રીય ફાર્માસ્યુટિકલ કંપની છે, જે ઉચ્ચ-ગુણવત્તાવાળા જેનરિક અને બ્રાન્ડેડ ફાર્માસ્યુટિકલ્સ, સક્રિય ફાર્માસ્યુટિકલ ઘટકો અને બાયોસિમિલર્સના ઉત્પાદન અને માર્કેટિંગમાં વિશેષતા ધરાવે છે. તે યુ.એસ. સાથે વૈશ્વિક સ્તરે કાર્ય કરે છે.

Advertisement
BOARD OF DIRECTORS
Girish Paman Vanvari
Independent Director
Savita Mahajan
Independent Director
DEPARTED
Venkat Nageswar Chalasani
Independent Director
DEPARTED
Deepali Pant Joshi
Additional Director